Cargando…
Anticoagulation in COVID-19: not strong for too long?
Autores principales: | Tacquard, Charles, Mansour, Alexandre, Godon, Alexandre, Gruel, Yves, Susen, Sophie, Godier, Anne, Albaladejo, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008784/ https://www.ncbi.nlm.nih.gov/pubmed/33798761 http://dx.doi.org/10.1016/j.accpm.2021.100857 |
Ejemplares similares
-
Reply to the authors of “Age-adjusted D-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients”()
por: Godon, Alexandre, et al.
Publicado: (2021) -
Response
por: Tacquard, Charles, et al.
Publicado: (2021) -
Response
por: Tacquard, Charles, et al.
Publicado: (2021) -
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
por: Susen, Sophie, et al.
Publicado: (2020) -
Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)
por: Godon, Alexandre, et al.
Publicado: (2021)